Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(2)
Other(2)

Detailed Status

unknown2
Terminated1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown240%
terminated120%
withdrawn120%
completed120%

Recent Activity

0 active trials
Showing 5 of 5
completed

Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry.

NCT05891743
unknown

The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)

NCT04085705
terminatednot_applicable

Cutaneous and Systemic Reactions to Metal Implants

NCT02483728
unknownnot_applicable

Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)

NCT03176342
withdrawnphase_3

Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents

NCT01518348

Clinical Trials (5)

Showing 5 of 5 trials
NCT05891743

Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry.

Completed
NCT04085705

The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)

Unknown
NCT02483728Not Applicable

Cutaneous and Systemic Reactions to Metal Implants

Terminated
NCT03176342Not Applicable

Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)

Unknown
NCT01518348Phase 3

Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5